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ABSTRACT
Theiler’s murine encephalomyelitis virus (TMEV) is a member of the genus Cardiovirus in the Picornaviridae, a family of posi-
tive-sense single-stranded RNA viruses. Previously, we demonstrated that in the related cardiovirus, Encephalomyocarditis vi-
rus, a programmed1 ribosomal frameshift (1 PRF) occurs at a conserved G_GUU_UUU sequence within the 2B-encoding
region of the polyprotein open reading frame (ORF). Here we show that1 PRF occurs at a similar site during translation of the
TMEV genome. In addition, we demonstrate that a predicted 3= RNA stem-loop structure at a noncanonical spacing downstream
of the shift site is required for efficient frameshifting in TMEV and that frameshifting also requires virus infection. Mutating the
G_GUU_UUU shift site to inhibit frameshifting results in an attenuated virus with reduced growth kinetics and a small-plaque
phenotype. Frameshifting in the virus context was found to be extremely efficient at 74 to 82%, which, to our knowledge, is the
highest frameshifting efficiency recorded to date for any virus. We propose that highly efficient1 PRF in TMEV provides a
mechanism to escape the confines of equimolar expression normally inherent in the single-polyprotein expression strategy of
picornaviruses.
IMPORTANCE
Many viruses utilize programmed1 ribosomal frameshifting (1 PRF) to produce different protein products at a defined ra-
tio, or to translate overlapping ORFs to increase coding capacity. With few exceptions,1 PRF occurs on specific “slippery” hep-
tanucleotide sequences and is stimulated by RNA structure beginning 5 to 9 nucleotides (nt) downstream of the slippery site.
Here we describe an unusual case of1 PRF in Theiler’s murine encephalomyelitis virus (TMEV) that is extraordinarily efficient
(74 to 82% of ribosomes shift into the alternative reading frame) and, in stark contrast to other examples of1 PRF, is depen-
dent upon a stem-loop structure beginning 14 nt downstream of the slippery site. Furthermore, in TMEV-based reporter con-
structs in transfected cells, efficient frameshifting is critically dependent upon virus infection. We suggest that TMEV evolved
frameshifting as a novel mechanism for removing ribosomes from the message (a “ribosome sink”) to downregulate synthesis of
the 3=-encoded replication proteins.
The genus Cardiovirus of the family Picornaviridae (a family ofpositive-sense single-stranded RNA viruses) currently con-
tains two species, Encephalomyocarditis virus (EMCV) and Thei-
lovirus. The latter encompasses a number of divergent viruses,
including Theiler’s murine encephalomyelitis virus (TMEV), rat
theilovirus (RTV), and Saffold virus (SAFV). The approximately
8-kb genome contains a long open reading frame (ORF) that is
translated as a polyprotein and subsequently processed by the vi-
rus-encoded 3C protease (1–3). Separation of the L-1ABCD-2A
and 2BC-3ABCD components, however, occurs cotranslationally
via a process termed “StopGo” or “Stop-Carry on” (4–6) (Fig. 1).
This unusual proteolysis-independent but ribosome-dependent
mechanism is mediated by the amino acid motif D(V/I)ExNPG|P
(where the symbol “|” represents the junction between 2A and
2B), together with less conserved but nonetheless functionally im-
portant upstream amino acids, which prevent the formation of a
peptide bond between Gly and Pro but allow the continuation of
translation with up to near-100% efficiency (7–11).
Many RNA viruses contain sequences that stimulate a propor-
tion of ribosomes to undergo a 1 frameshift and to continue
translating in an alternative reading frame. Where functionally
utilized, this is termed programmed1 ribosomal frameshifting
(1 PRF). In eukaryotic systems, the stimulatory elements for1
PRF typically involve a “slippery” heptanucleotide sequence,
where the shift in reading frame actually occurs, and a down-
stream RNA stem-loop or pseudoknot structure. The consensus
motif for the shift site sequence is X_XXY_YYZ, where XXX nor-
mally represents any three identical nucleotides (though certain
exceptions occur, including GGU), YYY represents AAA or UUU,
Z represents any nucleotide except G, and underscores separate
codons in the initial reading frame (12). During the frameshift, the
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P- and A-site tRNAs detach from the zero frame codons XXY and
YYZ and re-pair in the1 frame to XXX and YYY. Frameshifting
on a suitable shift site is stimulated to high levels (typically to a
final1 PRF efficiency of 5 to 45%, depending on the particular
frameshift sequence) by a downstream stimulatory element usu-
ally in the form of an RNA pseudoknot or a stem-loop structure,
separated from the shift site by a 5- to 9-nucleotide (nt) spacer (13,
14). RNA structures at this distance from the shift site are thought
to be located at the mRNA unwinding site of the mRNA entrance
channel of the ribosome when the shift site sequence is located
within the decoding center (15, 16). Failure to efficiently unwind
the RNA structure—perhaps due to the presentation of an un-
usual topology—is thought to interfere with ribosome progressiv-
ity and may also induce tension within the mRNA that leads to
uncoupling and subsequent realignment of the codon-anticodon
duplexes (15, 17, 18).
Recently, EMCV was shown to utilize 1 PRF at a conserved
G_GUU_UUU sequence positioned just downstream of the
StopGo site. Frameshifting results in the production of a novel
14-kDa “transframe” protein (termed 2B*) whose N-terminal 11
or 12 amino acids (depending on strain) are encoded within the
polyprotein open reading frame (ORF) and whose C-terminal 117
amino acids are encoded by an overlapping ORF in the1 reading
frame (19). In theiloviruses, a G_GUU_UUU sequence is con-
served at a similar position in the genome, but a long overlapping
ORF in the1 reading frame is lacking (Fig. 1). If1 PRF were to
occur at this site in these viruses, the resulting transframe protein
would be only 14 or 15 amino acids in length.
Here we show that1 PRF does indeed occur in TMEV and is
functionally important for virus propagation. Frameshifting in
TMEV is extraordinarily efficient (74 to 82%); to our knowledge,
this is the highest frameshifting efficiency reported to date for any
virus. We also demonstrate that a 3= RNA stem-loop structure is
involved in frameshift stimulation but acts from a location further
downstream of the slippery sequence (14 nt) than is typical (5 to 9
nt). As in EMCV, but in contrast to nearly all other known cases,
frameshifting in TMEV depends on virus infection, suggesting the
involvement of a frameshift-stimulatory trans-acting factor.
MATERIALS AND METHODS
Viruses and cell culture. BHK-21 cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum (FBS), 1 mM L-glutamine, and antibiotics. In virus infections,
BHK-21 cells were washed with DMEM containing no serum (SFM) and
overlaid with wild-type (WT) TMEV or mutant derivatives at the multi-
plicities of infection (MOIs) stated below. After a 1-h adsorption period,
virus was removed, and cells were overlaid with DMEM supplemented
with 2% FBS for various times.
The GDVII strain of TMEV generated from the full-length infectious
clone pSK-GDVII was used (a kind gift from the Robert Fujinami lab,
University of Utah). The sequence of this clone is identical to GenBank
accession no. NC_001366.1 except for three nucleotide differences:
G2241A (serine to isoleucine in VP2), A2390G (synonymous change in
VP3), and G4437A (lysine to glutamine in 2B). Nucleotide coordinates
herein are given with respect to NC_001366.1 (20).
Recombinant viruses and plasmids. QuikChange mutagenesis (Agi-
lent Technologies) was performed on a template containing the full-
length viral insert to create the full-length recombinant TMEV shift site
mutant (SS), stop codon mutant (SCM), and StopGo mutant (LVWT).
All constructs were verified by sequencing of the complete virus genome.
V5 and HA-tagged virus variants were created as follows. First, two
unique restriction sites (a BsiWI site starting at nt 4166 and a SalI site
starting at nt 4536) were introduced (using synonymous changes) into a
subclone by site-directed mutagenesis, and the fragment was cloned back
into the full-length clone. Two PCR products were then generated using
primers overlapping these restriction sites at one end and primers span-
ning the TMEV sequence and part of the V5 or HA sequence at the other.
These fragments fused the first codon following the StopGo junction with
the 5= terminus of the tag coding region and the 3= terminus of this region
with the rest of the 2B/2B* sequence. Different variants were produced to
allow the generation of tagged WT, SS, LVWT, and StopGo and shift site
mutant (LVSS) clones. The fragments were joined by overlap extension
PCR and subcloned back into the modified full-length clone containing
the extra restriction sites. The V5 tag, including a glycine-serine linker,
was GKPIPNPLLGLDSTGSGSGS, while the HA tag was YPYDVPDYA.
Dual-luciferase frameshift reporter plasmids were prepared by intro-
ducing annealed oligonucleotide pairs into XhoI/BglII-digested pIDluc.
Plasmid pIDluc is a derivative of the pDluc vector with the mengovirus
internal ribosome entry site (IRES) (DQ294633, nt 256 to 770) inserted
downstream of the T7 promoter of pDluc such that the second codon of
the Renilla luciferase gene is fused to the first seven codons of the mengo-
virus polyprotein ORF, allowing cap-independent translation.
In vitro transcription and generation of recombinant virus. Plas-
mids were linearized with XbaI and transcribed with T7 RNA polymerase
(Ambion) for 3 h at 37°C as recommended by the manufacturer. RNA
integrity was confirmed by electrophoresis, and RNA was transfected into
BHK-21 cells using DMRIE-C (Invitrogen) according to the manufactur-
er’s recommendations. Once cytopathic effect was observed, cells were
subjected to three rounds of freeze-thawing, followed by centrifugation
for 5 min at 5,000 rpm to pellet cell debris. Virus-containing supernatant
was titrated and stored at80°C.
Plaque assays.BHK-21 cells at70 to 80% confluence in 6-well plates
were infected with 10-fold dilutions of virus for 1 h at 37°C. Cells were
overlaid with DMEM supplemented with carboxymethyl cellulose (CMC;
0.35% each of low- and high-viscosity CMC) and 2% FBS and incu-
FIG 1 Schematic representation of the TMEV genome. The predicted1 PRF site is situated at codons 5 and 6 downstream of the junction between the 2A and
2B coding sequences. Frameshift translation would yield a 14-aa transframe protein termed 2B*, whose N terminus would be encoded in the polyprotein frame
(blue) and whose C terminus would be encoded in the1 frame (pink).
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bated at 37°C for 48 h. After incubation, cells were fixed using formal
saline and stained using 0.1% toluidine blue.
One-step growth curves. BHK-21 cells were infected with WT, SS,
SCM or LVWT TMEV at an MOI of 10 and incubated at 37°C for 1 h. Cells
were washed twice in ice-cold phosphate-buffered saline (PBS) and over-
laid with 2% DMEM. Virus was harvested at time points indicated below,
and the titers were determined using a plaque assay.
Competition assays. BHK-21 cells in six-well plates were infected
with either WT and SS or WT and SCM at an MOI of 0.1. After adsorp-
tion, cells were washed with PBS and overlaid with 2% DMEM (2 ml) and
incubated for 24 h, after which virus was harvested (passage 1) and 250l
was used to reinfect fresh BHK-21 cells. This was repeated five times. RNA
was extracted from virus harvested at each passage using TRIzol-LS
(Sigma) according to the manufacturer’s instructions. A total of 1,500 ng
of RNA was reverse transcribed using avian myeloblastosis virus (AMV)
reverse transcriptase (Promega) for 1 h at 42°C. The cDNA generated was
used as the template for PCR amplification of a region encompassing the
frameshift site using specifically designed primers. PCR products were
purified using the Promega PCR purification kit and subsequently se-
quenced.
Metabolic labeling. BHK-21 cells at 90 to 100% confluence in 24-well
plates were infected with WT, SS, SCM, or LVWT TMEV at an MOI of 10.
After 60 min adsorption at 37°C, virus inocula were removed by aspira-
tion and replaced with 2% DMEM, and the cells were incubated at 37°C
for 6 h. Cells were subsequently washed once with methionine-free
DMEM and incubated in 1 ml of methionine-free DMEM for 1 h. Cells
were labeled with [35S]methionine (200 Ci/ml) at 37°C for 1 h. Cells
were scraped into 0.4 ml ice-cold PBS and spun at 5,000 rpm for 5 min.
Cell pellets were washed with ice-cold PBS, resuspended in 70 l Laem-
mli’s sample buffer, heated at 95°C for 5 min, and analyzed by SDS-PAGE
(6 to 15%). After electrophoresis, gels were fixed, dried, and subjected to
phosphorimaging. Frameshifting efficiencies were estimated from band
intensities quantified using the software ImageQuant TL, as described in
Results.
Antibodies. The antibody (Ab) against TMEV protein VP1 (mouse
monoclonal) has been described previously (21). Rat monoclonal anti-
tubulin Ab, mouse monoclonal anti-HA Ab, and agarose-conjugated V5
and HA antibodies used for the immunoprecipitation of tagged viral pro-
teins were from Sigma. Mouse monoclonal anti-V5 Ab was from Life
Technologies, and IRDye-conjugated secondary antibodies used for im-
munoblotting were from Li-Cor.
Immunoblotting.BHK-21 cells were infected with TMEV WT or mu-
tants thereof at an MOI of 10. Infected cells were lysed directly in Laem-
mli’s sample buffer and heated to 95°C for 5 min. Proteins were separated
on gels as indicated in the figure legends and transferred to nitrocellulose
membranes. These were blocked for 30 to 60 min with 5% powdered milk
(Marvel) in PBS containing 0.1% Tween 20 (PBST) and probed at 4°C
overnight with primary antibody. Membranes were washed in PBST prior
to incubation in the dark with an IRDye-conjugated secondary antibody
in PBST. Blots were scanned using an Odyssey infrared imaging system
(Li-Cor).
Mass spectrometry. Infected BHK-21 cells from a 25-cm2 flask were
washed in cold PBS and lysed in radioimmunoprecipitation assay (RIPA)
buffer (50 mM Tris HCl [pH 8], 150 mM sodium chloride, 1% NP-40
substitute, 0.5% sodium deoxycholate, 0.1% SDS) plus protease inhibi-
tors and Benzonase (Merck) on ice for 20 min. Cell debris was removed by
centrifugation at 21,000 g at 4°C for 10 min. Cell lysates were incubated
with 50 l of protein A Sepharose in RIPA buffer and 0.5 l of an irrele-
vant goat antibody for 1 h at 4°C with gentle mixing. Lysates were centri-
fuged through SigmaPrep columns at 8,200 g at 4°C for 1 min, and the
supernatant was incubated overnight with 200 l of anti-V5 conjugated
agarose beads (Abcam) on an end-over-end mixer at 4°C. Beads were
washed three times in a high-salt wash (0.5 M LiCl, 0.1 M Tris-HCl [pH
8.5]) before resuspension in Laemmli’s sample buffer and boiling for 7
min to remove protein from the beads. Proteins were separated by elec-
trophoresis on a 12% bis-Tris urea gel run in morpholineethanesulfonic
acid (MES) buffer (Invitrogen) at 30 to 40 mA for optimal resolution. The
gel was washed and stained using colloidal Coomassie blue, and bands
were excised for mass spectrometry.
Coomassie blue-stained products were excised from the gel and sub-
jected to in-gel trypsin digestion. Peptides were extracted and analyzed by
liquid chromatography-tandem mass spectrometry (LC-MS/MS) using
an Agilent 1200 series nanoflow system (Agilent Technologies) connected
to a LTQ Orbitrap mass spectrometer (Thermo Electron) equipped with a
nanoelectrospray ion source (Proxeon). Fragment MS/MS spectra were
searched with the Mascot 2.3 search engine (Matrix Science) against a
protein sequence database composed of expected viral target sequences
and common contaminant proteins such as trypsin and keratins. Search
parameters included a 5-ppm precursor mass tolerance and 0.6-Da
MS/MS mass tolerance, three missed trypsin cleavages, and trypsin cleav-
age before proline plus a number of variable modifications, such as oxi-
dation (M), oxidation (HW), phospho (ST), and phospho (Y). For the
figures, spectra were autoannotated with xiSPEC (http://spectrumviewer
.org).
Dual-luciferase assays. BHK-21 cells were transfected in triplicate
with the relevant plasmid using Lipofectamine 2000 reagent (Invitrogen)
in a 24-well plate. Transfected cells were incubated at 37°C for 18 h prior
to infection with WT TMEV at an MOI of 10. Luciferase activities were
determined using the dual-luciferase Stop & Glo reporter assay system
(Promega) at 7 h postinfection (p.i.). Transfected cells were washed once
with PBS and lysed in 100l of 1 passive lysis buffer, and light emission
was measured following injection of 50l of either Renilla or firefly lucif-
erase substrate. Firefly luciferase activity was calculated relative to the
activity of Renilla luciferase, and frameshifting efficiencies were deter-
mined by comparing the ratio of firefly to Renilla enzymatic activities in
parallel cell cultures transfected with either the test construct or an in-
frame control (IFC), as described previously (24).
RESULTS
Mutating the predicted frameshift site attenuates virus growth.
In the GDVII strain of TMEV, the mass of the predicted 14-ami-
no-acid (aa) transframe fusion protein that would arise from1
PRF is only 1.4 kDa. Products of such small size are inherently
difficult to detect by SDS-PAGE and/or Western blotting. There-
fore, we decided to first seek genetic evidence for the functional
importance of the predicted frameshift site in TMEV through mu-
tagenesis of an infectious clone. Three mutants were generated
(Fig. 2A): (i) G_GUU_UUU to A_GUG_UUU (mutations are in
bold) at nt 4244 to 4250 to prevent frameshifting at the predicted
shift site (SS); (ii) ACU_AAA to ACA_AAA at nt 4272 to 4277 to
remove the UAA stop codon of the predicted 2B* product, thus
extending it by a further 21 aa in length (SCM); and (iii) GGC_CCU
toCUG_GUC at nt 4230 to 4235 to inhibit StopGo by introducing
GP-to-LV amino acid changes at the junction between 2A and 2B
(LVWT). This mutation was shown previously to inhibit StopGo
from occurring, thereby fusing the 2A and 2B (or 2B*) proteins
together, and this mutant was constructed to assess the relative
importance of StopGo and frameshifting for TMEV replication
and to assess whether StopGo affects frameshifting. The SS and
SCM mutations do not change the polyprotein amino acid se-
quence.
RNA transcribed from the WT, SS, SCM, and LVWT molecu-
lar clones was transfected into BHK-21 cells to generate virus
stocks which were analyzed by plaque assay. While the StopGo
mutant (LVWT) and 2B* extension mutant (SCM) produced
plaque sizes similar to those of the WT, the shift site mutant (SS)
gave significantly smaller plaques (Fig. 2B). The growth pheno-
types of WT, SS, SCM, and LVWT viruses were analyzed further
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using one-step growth curve analysis (Fig. 2C). As in the plaque
assays, SS exhibited a marked defect in growth kinetics, with peak
titers 1.5 log lower than those of the WT. SCM exhibited a slight
attenuation in replication, reaching peak titers around half a log
lower than those observed for WT. In agreement with results re-
ported by Loughran and colleagues (22), the LVWT growth curve
closely mirrored that of the WT, with only a slight lag in replica-
tion kinetics.
To further investigate fitness of the SCM and SS mutants, a
competition assay was performed, whereby a mixture of equal
amounts of WT and mutant virus was used to infect BHK-21 cells
and the sequences of the resulting progeny were determined fol-
lowing RNA extraction. At various passage numbers, we assessed
whether and how quickly the WT virus was able to outcompete
either mutant. Consistent with the single-cycle growth curves de-
scribed above, WT virus was able to outcompete SS within one
passage (approximately two full WT replication cycles), while for
SCM, after one passage, the ratio of SCM to WT RNA was approx-
imately 1:10. At later passages, the SCM sequence disappeared
completely, leaving only the WT sequence (Fig. 2D). Together,
these results provide genetic evidence for the functional impor-
tance of the predicted frameshift site in TMEV.
Frameshifting in the viral context is highly efficient. If frame-
shifting does indeed occur in TMEV, then, since ribosomes that
frameshift would terminate and dissociate from the message at the
2B* stop codon (Fig. 1), there should be fewer ribosomes synthe-
sizing polyprotein products encoded downstream of the frame-
shift site (2BC-3ABCD) than polyprotein products encoded up-
stream of the frameshift site (L-1ABCD-2A). To investigate this,
we used metabolic labeling to quantify viral protein production.
In TMEV, the frameshifting efficiency cannot be robustly esti-
mated simply by analyzing the ratio of upstream and downstream
products for WT virus, due to the presence of intermediate poly-
protein processing products, as well as potential differences in
protein turnover rates. However, by normalizing WT protein lev-
els to the corresponding levels for the SS mutant—in which pro-
teins encoded upstream and downstream of the shift site are ex-
pected to be produced in equimolar amounts—we can at least
partly correct for these confounding factors.
[35S]methionine-labeled proteins from infected cell lysates
were separated by electrophoresis and quantified by phosphorim-
aging. The expression levels of products encoded downstream of
the predicted shift site were observed to be much lower, relative
to the upstream products, for WT virus than for the SS mutant
FIG 2 Analysis of TMEV mutants. (A) Schematic representation of mutations. SS, shift site mutant; SCM, 2B* extension mutant; LVWT, StopGo mutant. The
shift site sequence is in blue, and the 2B* stop codon is in red. (B) Mean plaque sizes for TMEV WT and mutant viruses. Mean plaque sizes are the averages for
100 representative plaques; error bars indicate standard deviations. **, SS is significantly different from WT (two-tailed t test, P 0.001). (C) One-step growth
curves. BHK-21 cells were infected with WT, SS, SCM, or LVWT viruses at an MOI of 10 and harvested at the indicated time points. Titers were measured by
plaque assay. At least two biological repeats were performed for each virus; error bars indicate standard deviations. (D) Competition assay. BHK-21 cells were
infected with a mixture of an MOI of 0.1 of either SS plus WT or SCM plus WT viruses. At 24 h p.i., virus was harvested and used to reinfect BHK-21 cells.
Passaging was repeated five times. RNA was extracted from passages 0, 1, and 5, and a region of1,000 nt encompassing the mutated region was sequenced.
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(Fig. 3A), indicating that a substantial proportion of ribosomes
leave the polyprotein frame in the vicinity of the frameshift site
and that this departure is mediated by the sequence of the pre-
dicted frameshift site. This is most obvious when the intensities of
the 2C and VP1 proteins are compared. The intensity of each band
depends on the number of methionines present and the abun-
dance of the protein. There is clearly much more of the down-
stream product 2C relative to VP1 in the SS sample than in the
WT, LVWT, and SCM samples.
The relative abundances of individual TMEV proteins were
calculated by normalizing the intensity of each band first by the
number of methionines in the corresponding product, then by the
means of these values for VP0, VP1, and VP3 (to control for lane
loading), and finally by the corresponding similarly normalized
band for the SS mutant (Fig. 3B). This highlights the substantial
fall in relative protein levels between the upstream products (VP0,
VP3, VP1, and 2A) and the downstream products (2C and 3D).
Due to the relatively high background and low intensity of the 2B
and 3C bands, it was not possible to reliably estimate the levels of
these proteins for the WT and LVWT viruses, although their rel-
ative expression levels are clearly much lower than for the SS mu-
tant (Fig. 3A).
In order to calculate frameshifting efficiencies, the intensity of
each of the VP0, VP3, VP1, and 2C bands from WT, LVWT, and
SCM was normalized first by methionine content, then by the
mean of these values for VP0, VP1, and VP3 (to control for lane
loading), and then by the corresponding similarly normalized val-
ues for the SS mutant as described above. Then, the value for 2C
(downstream product) was divided by the average of the values for
VP0, VP3, and VP1 (upstream products). (2A and 3D were ex-
cluded, as these products were not always clearly resolved and
quantifiable.) This provides an estimate of the fraction of ribo-
somes that avoid a 1 PRF. Subtracting this value from 1 and
multiplying the result by 100 gives the percent frameshifting effi-
ciency (Fig. 3C). Using this method, the frameshifting efficiency
for WT virus was estimated as 74 to 82% (95% confidence inter-
val; n  5) (Fig. 3C). With the exception of one outlier, LVWT
behaved similarly to the WT virus (n  5) (Fig. 3C). SCM had a
frameshifting efficiency of 53 to 75% (95% confidence interval;
n  2) which was significantly lower than the WT frameshifting
FIG 3 Analysis of frameshifting in the viral context. (A) Radiolabeled TMEV translation products. BHK-21 cells were infected with either WT, SCM, SS, or
LVWT viruses at an MOI of 8 or mock infected. Cells were labeled from 6 to 7 h p.i. and harvested at 7 h p.i., and proteins were separated by SDS-PAGE. Note
that the more slowly migrating 2A band for LVWT may contain both 2A-2B* and a 2A-2B cleavage product. All samples were run on the same gel; an irrelevant
lane has been excised. (B) Relative amounts of TMEV proteins. Individual band intensities for WT, LVWT, and SCM were normalized first by methionine
content, then by the means of these values for VP0, VP1, and VP3 (to control for lane loading), and then by the corresponding similarly normalized band for SS.
Each bar represents the mean ( standard deviation) from all biological repeats in which the corresponding band could be resolved and quantified (see the text).
(C) Frameshifting efficiency. The intensity in each of the VP0, VP3, VP1, and 2C bands for WT, LVWT, and SCM viruses was normalized first by methionine
content, then by the means of these values for VP0, VP1, and VP3 (to control for lane loading), and then by the corresponding similarly normalized values for
SS. Then the value for 2C (downstream product) was divided by the average of the values for VP0, VP3, and VP1 (upstream products). Subtracting this value from
1 and multiplying the result by 100 gives the percent frameshifting efficiency. Each bar represents the mean value ( standard deviation) from five, five, and two
biological repeats for WT, LVWT, and SCM viruses, respectively.
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efficiency (P  0.003, 2-tailed pooled variance t test), indicating
that the SCM mutation may have partly interfered with a frame-
shift-stimulating element. It should be noted that this calculation
assumes that ribosomes either frameshift or continue translating
in the polyprotein frame; however, it is also possible that a pro-
portion of ribosomes prematurely terminate at the frameshift site
(23).
Mass-spectrometric confirmation of 2B* expression and the
site of frameshifting. To confirm1 PRF at the predicted frame-
shift site and translation of the predicted 2B* peptide, mass spec-
trometry was utilized. Purification of WT 2B* proved to be im-
practicable given its small size (1.4 kDa) and poor predicted
antigenicity. Therefore, we generated viruses expressing V5-
tagged 2B*. Sequences encoding a V5 tag and linker were inserted
just after the last codon of the StopGo sequence (proline in the WT
virus and valine in the LV mutants) in the WT, SS, LVWT, and
LVSS (a poorly growing mutant in which both StopGo and the
shift site were disabled) viruses (Fig. 4A). In this location, V5 is
expected to tag both 2B and 2B* near their N termini. Frameshift-
ing efficiencies were estimated from radiolabeled products as
described above and were found to be similar to those of the re-
spective untagged viruses (Fig. 4B). These data indicate that the
V5-tagged viruses mimic their untagged counterparts during vi-
rus replication in cell culture.
Following this initial characterization, BHK-21 cells were in-
fected with V5-tagged WT, SS, LVWT, or LVSS viruses and lysed
when cytopathic effect was extensive. Proteins were separated by
SDS-PAGE, and V5-tagged products were detected by Western
blotting (Fig. 4C). For V5-tagged WT virus, no product was ob-
served migrating at a size compatible with that expected for V5-
tagged 2B* (3.3 kDa), suggesting that this product may be rapidly
degraded (data not shown). The predicted size of the V5-tagged
2A-2B* fusion that would be produced when StopGo is inhibited
in LVWT virus is 18.8 kDa. A doublet (possible explanation be-
low) migrating at a position consistent with this size was observed
for both the V5-tagged WT and LVWT viruses, whereas for the
V5-tagged shift site mutant viruses (SS and LVSS), only a single
band was observed to migrate at this position. We hypothesized
that the additional band seen in WT and LVWT, but not in the
shift site mutants, represented the frameshift product 2A-V5-2B*
(18.8 kDa) (produced at a low level in V5-tagged WT virus only
when StopGo separation fails; see below).
Next, we performed an anti-V5 immunoprecipitation using
lysate from cells infected with V5-tagged LVWT. Immunoprecipi-
tates were separated by SDS-PAGE and stained with colloidal
Coomassie blue. Again, a doublet was observed migrating at the
appropriate size. Both bands were excised and digested with tryp-
sin, and the resulting peptides were analyzed by liquid chroma-
tography-tandem mass spectrometry (LC-MS/MS). Peptides cov-
ering 98% or 96% of the predicted 2A-V5-2B* fusion were
identified from each band in the doublet (although some of these
peptides may have arisen from comigrating nonframeshift prod-
ucts; see below). Importantly, however, the peptide encoded by
the shift site sequence was identified, thus confirming both the site
and the direction (1) of the frameshift (Fig. 4D; also, see Fig. S1A
in the supplemental material).
Peptides were also mapped to a portion of the 2B protein. Near
the N-terminal end of 2B, there is a potential 3C-Pro cleavage site,
QG, that is conserved in theiloviruses and EMCV (19). When
StopGo fails (WT) or is inhibited (LV), cleavage at this site would
produce a V5-tagged product comprising 2A fused to V5 and the
N-terminal 9 aa of 2B. This product (2A-V5-2BN) has a predicted
mass of 18.4 kDa and would migrate close to 2A-V5-2B*. Peptides
confirming usage of this cleavage site were observed during mass
spectrometry of both bands (Fig. 4D; also, see Fig. S1B in the
supplemental material). Thus, the doublet seen in the Western
blot for V5-tagged LVWT may comprise both 2A-V5-2B* and
2A-V5-2BN, with the detection of both products in both bands
simply indicating that the doublet was not resolved well enough to
avoid contamination between the two gel slices. This doublet was
also observed for V5-tagged WT virus, and this likely results from
a proportion of ribosomes reading through the StopGo cassette
without cotranslational separation occurring, leaving a propor-
tion of 2A fused to V5 and 2B* or 2BN.
A sequence encoding an HA tag was also inserted into the
LVWT backbone, and anti-HA immunoprecipitation was used to
purify 2A-HA-2B* for LC-MS/MS analysis. The sequence data
obtained were consistent with that of the V5-tagged viruses, with
high coverage of the 2A-HA-2B* product and recovery of the shift
site peptide, again verifying the site and direction of frameshifting
(Fig. 4D; also, see Fig. S1C in the supplemental material). These
experiments confirm that 1 PRF does indeed occur on the
G_GUU_UUU motif during translation of the TMEV genome.
These findings also help explain the migration patterns ob-
served for the low-molecular-mass radiolabeled products of the
eight viruses (Fig. 4E). In the untagged StopGo mutant viruses, a
product migrating slightly more slowly than 2A may represent
comigrating 2A-2B* and 2A-2BN in LVWT and 2A-2BN alone in
LVSS. In the tagged StopGo mutant viruses, this was replaced with
a still more slowly migrating band, consistent with 2A-V5-2B* or
2A-V5-2BN (the three prolines in the V5 tag may explain their
aberrant migration relative to 2A and 2A-2B*/2A-2BN). In con-
trast, the band presumed to correspond to 2B (note that the other
downstream low-mass viral products, 3A and 3AB, lack methio-
nines) did not shift between untagged and tagged viruses (e.g., SS)
(Fig. 4E), nor between wild-type and mutant StopGo viruses (e.g.,
cf. SS with LV-SS in Fig. 4E), suggesting that this band actually
represents N-terminally cleaved 2B.
Frameshifting is stimulated by virus infection and requires a
3= stem-loop structure. Previously, frameshifting in the related
EMCV was shown to depend upon virus infection and on at least
50 nt of the 3= sequence (19). The EMCV 3= sequence is predicted
to form a stem-loop at an unusual distance from the shift site.
However, the role of the predicted structure in EMCV frameshift-
ing remains uncertain, as all mutations tested in a reporter sys-
tem— even ones predicted to restore the stem-loop structure but
with an altered sequence—inhibited frameshifting (19). A stem-
loop with similar spacing (14 nt) is also predicted in TMEV (Fig.
2A). To investigate the important elements for TMEV frameshift-
ing, we cloned the relevant region into a dual-luciferase reporter
construct, pIDluc, which is a modified version of pDluc (24, 25).
As picornavirus infection results in host translational shutoff,
pDluc was adapted to contain the EMCV IRES to allow cap-inde-
pendent translation during viral infection. The TMEV WT shift
site sequence (G_GUU_UUU) or mutated shift site sequence (SS;
A_GUG_UUU), together with 6 nt of upstream sequence and 92
nt of downstream sequence (including the predicted stem-loop
structure), was cloned between the Renilla and firefly luciferase
ORFs in pIDluc such that frameshifting is required for expression
of the firefly ORF. Two additional changes were introduced: a
Ribosomal Frameshifting in TMEV

















FIG 4 Characterization of tagged viruses. (A) Schematic representation of the tagged viruses. A V5 tag was inserted just after the first proline of 2B in the WT
sequence (after valine in the GP-to-LV StopGo-mutated viruses), to tag products containing 2B or 2B*. (B) Frameshifting efficiencies of tagged and untagged
viruses. BHK-21 cells were infected with WT, SS, LVWT, or LVSS viruses or their tagged equivalents, and frameshifting efficiencies were calculated from
radiolabeled products as described in Fig. 3C. All viruses were normalized by SS; thus, the frameshifting efficiency for SS is zero by definition. Negative
frameshifting efficiencies are likely an artifact of measurement errors and/or biological variability. Each bar represents the mean value ( standard deviation)
from three biological repeats (the three untagged WT and LVWT data points are also used in Fig. 3C). (C) Western blot of virus-infected cell lysates. BHK-21 cells
were infected with V5-tagged viruses at MOI of 1 for LVSS, 5 for SS, and 10 for WT and LVWT, and lysates were prepared when cytopathic effect was extensive.
Fivefold-smaller amounts of the LVWT and LVSS samples were loaded to give band intensities similar to those of the WT and SS samples, where only proteins
generated by StopGo failure are detected. The proteins with the GP-to-LV mutation may migrate slightly faster than the wild-type ones. Samples were run on
bis-Tris gels with 6 M urea and MOPS buffer, which results in altered mobility of the prestained 14-kDa and 17-kDa markers. (D) Mass spectrometric analysis
of tagged products. Lysates from BHK-21 cells infected with V5- or HA-tagged TMEV LVWT were immunoprecipitated with V5 or HA antibodies, respectively,
and immunoprecipitates were separated by SDS-PAGE. Products migrating at the expected size for 2A-tag-2B* were subjected to in-gel trypsin digest, and
peptides were analyzed by LC-MS/MS. Fragmentation ions are shown for the shift site peptide derived from V5-tagged 2A-2B* (top), a peptide consistent with
3C-Pro cleavage of tagged 2A-2B at the conserved Q|G encoded just downstream of the frameshift site (middle), and the shift site peptide derived from HA-tagged
2A-2B* (bottom). Amino acids derived from the V5 or HA tag are in green. The b- and y-series ions correspond to N- and C-terminal fragments. See Fig. S1 in
the supplemental material for the fragmentation spectra. Below, the nucleotide sequence in the vicinity of the shift site G_GUU_UUU is shown, with conceptual
amino acid translations in all three reading frames. The C-terminal end of the frameshift tryptic peptide is underlined in green, and the C-terminal end of the 2B
cleavage peptide is in blue. (E) Low-molecular-mass radiolabeled TMEV translation products. BHK-21 cells were infected with WT, SS, LVWT, or LVSS viruses
or their tagged equivalents at an MOI of 10 or mock infected. Cells were labeled from 8 to 9 h p.i. and harvested at 9 h p.i., and proteins were separated by
SDS-PAGE.
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U-to-C mutation (removing the1 frame stop codon) was intro-
duced into all plasmids to allow1 frame translation to continue
into the downstream firefly luciferase, and a CAA-to-UAA muta-
tion was introduced to generate a stop codon in the zero frame at
the third codon after the shift site. The latter mutation was intro-
duced as preliminary experiments indicated that, without it, the
extended C-terminal tail that is appended to the Renilla luciferase
when frameshifting failed to occur was inhibiting its enzymatic
activity. An in-frame control (IFC) in which the firefly ORF was
placed in the same frame as the Renilla ORF by inserting an extra
U at the end of the G_GUU_UUU shift site was also constructed.
Plasmids pIDluc SS, pIDluc WT, and pIDluc IFC were trans-
fected into BHK-21 cells 18 h prior to either mock infection or
infection with WT virus at an MOI of 10. Frameshifting efficien-
cies were measured to be 1% for pIDluc WT in mock-infected
cells but12 to 13% in TMEV-infected cells, showing that, as in
EMCV, frameshifting on the TMEV frameshift sequence is depen-
dent on virus infection (Fig. 5A). As expected, pIDluc SS failed to
support frameshifting either with or without virus infection. To
test whether frameshift stimulation by TMEV infection is re-
stricted to the TMEV frameshift signal, two other dual-luciferase
constructs harboring unrelated frameshift signals from infectious
bronchitis coronavirus (pDluc IBV) and human immunodefi-
ciency virus type 1 (p2luc HIV) (26), and their corresponding
IFCs were tested alongside the TMEV constructs. In these con-
structs, frameshifting occurred in mock-infected cells at levels
consistent with previous work (26), and the frameshifting effi-
ciencies were not increased by TMEV infection (Fig. 5A and B).
Canonical eukaryotic1 PRF is stimulated by a stable 3= RNA
secondary structure separated from the shift site by a 5- to 9-nt
spacer sequence. However, the predicted stem-loop in EMCV and
TMEV is separated from the shift site by 13 or 14 nt (19). In order
to evaluate whether the predicted stem-loop is involved in the
stimulation of frameshifting in TMEV, three mutants were gener-
ated (Fig. 5C): (i) pIDluc SL5=, where the first three bases of the 5=
half of the stem were mutated (5=-GGU-3= to 5=-CCA-3=); (ii)
pIDluc SL3=, where the last three bases of the 3= half of the stem
were mutated (5=-ACC-3= to 5=-UGG-3=); and (iii) pIDluc
SL5=	3=, where both sets of mutations were combined so as to
restore the predicted structure but with reversed base pairings. For
each mutant, a corresponding IFC was constructed. Frameshifting
efficiencies for both pIDluc SL3= and pIDluc SL5= were found to
be negligible even with TMEV infection (Fig. 5D). In contrast, the
frameshifting efficiency for the restoration mutant (pIDluc
SL5=	3=) was19% when stimulated by TMEV infection, similar
to that for pIDluc WT. This strongly indicates that the predicted 3=
RNA stem-loop structure does indeed form and plays a critical
role in the stimulation of frameshifting in TMEV.
DISCUSSION
We have demonstrated that TMEV utilizes1 PRF at a conserved
G_GUU_UUU sequence in the 2B-encoding region of the poly-
protein ORF. A virus (the SS mutant) with the predicted frame-
shift site disabled by mutations synonymous in the polyprotein
frame exhibited a small-plaque phenotype and attenuated growth
kinetics compared to WT virus. Moreover, using a V5-tagged
StopGo mutant virus, a product of the expected size for frameshift
translation was detected by anti-V5 Western blot, and the site and
direction of frameshifting confirmed by mass spectrometry of this
product. Analysis of the ratio of structural to nonstructural pro-
teins using metabolic labeling, comparing WT virus with the SS
mutant revealed that frameshifting efficiency in the viral context is
exceptionally high, at 74 to 82%.
When the TMEV frameshift cassette was cloned into a dual-
luciferase reporter, frameshifting was found to be dependent
upon viral coinfection, indicating that a virus-stimulated trans-
acting factor may be required for efficient frameshifting. Frame-
shift stimulation also involves a downstream RNA stem-loop
structure at a noncanonical spacing (14 nt) from the frameshift
site. While canonical 1 PRF-stimulatory RNA structures (5- to
9-nt spacing) are expected to be positioned partly within the
mRNA entrance channel at the onset of frameshifting, the cardio-
virus stem-loop structure will be located close to the leading edge
of the ribosome when the P and A sites are positioned on the shift
site sequence. One possible explanation for the observations may
be that a virus protein, or virus-stimulated host protein, binds to
the stem-loop structure and that this RNA-protein complex is able
to mimic a canonical 1 PRF-stimulatory RNA structure at a
different spacing or otherwise interact with the ribosome to pro-
mote1 PRF. Recent work onPorcine reproductive and respiratory
syndrome virus (family Arteriviridae) has demonstrated that in at
least one other case of ribosomal frameshifting, the 3= stimulator
involves mRNA-protein interactions (27).
Frameshifting efficiencies in the virus context were estimated
from polyprotein processing products quantified by metabolic la-
beling. Although we cannot rule out the possibility that the kinet-
ics of polyprotein processing may be modified in the mutants, the
very high efficiency of the TMEV frameshifting signal is consistent
with recent metabolic labeling and ribosome profiling data for the
cardiovirus EMCV, where frameshifting was found to be 50 to
70% efficient (R. Ling , J. D. Jones, I. Brierley, and A. E. Firth,
unpublished data). Why frameshifting is noticeably less efficient
in the context of the dual-luciferase reporter system (although still
TMEV infection dependent) is uncertain, although similar obser-
vations have been reported for EMCV (7% in pDluc [20]). One
possibility is that distal frameshift-stimulatory elements exist in
the virus genome that are not present in the dual-luciferase re-
porter vector. A more likely explanation, however, is that the re-
duced frameshifting efficiency is a consequence of a relative
buildup of the nonframeshift product (Renilla luciferase) in cells
prior to the onset of virus-stimulated frameshifting. A reduced
frameshifting efficiency would perhaps also be observed if the du-
al-luciferase reporter mRNA and “virus transactivator” were not
appropriately localized in the cell or if the reporter was present at
an inappropriate molar ratio.
Frameshifting at the same genomic location was previously
demonstrated in the related cardiovirus, EMCV (19). However, in
EMCV, frameshifting results in the production of a much larger
transframe 2B* protein (128 or 129 aa, depending on the isolate)
than in TMEV (14 aa). In EMCV, a mutation (PTC2) that trun-
cated 2B*, but that was not expected to interfere with frameshift-
ing, produced an intermediate phenotype, suggesting that both
the 2B* protein and frameshifting per se are functionally impor-
tant (19). In TMEV, frameshifting is critical for efficient viral
growth in cell culture, but it is unclear whether the 14-aa 2B* has
a function in its own right or whether it is simply the by-product of
a functionally important frameshift. Frameshifting in TMEV di-
verts 74 to 82% of ribosomes out of the polyprotein reading frame,
thus greatly reducing expression of the 3=-encoded replication
proteins relative to the 5=-encoded structural proteins. This, in
Ribosomal Frameshifting in TMEV

















itself, may provide a selective advantage, as the structural proteins
are required in much greater quantities than the replication pro-
teins. Although the mutant with 2B* extended (the SCM mutant)
exhibited a slight defect in growth kinetics compared to WT, this
could be due to a reduction in frameshifting efficiency since the
mutation is within the frameshift-stimulatory stem-loop struc-
ture and radiolabeling indicated that this mutant had a decreased
frameshifting efficiency (Fig. 3C). At this time, however, a func-
tional role for TMEV 2B* cannot be ruled out.
The StopGo process that cotranslationally separates the poly-
protein between 2A and 2B is conserved between TMEV and
EMCV and is essential for efficient replication in EMCV (8). How-
ever, consistent with previous results (22), our data show that
StopGo in TMEV is not crucial for efficient viral growth in cell
culture, as judged by the similar growth kinetics and plaque phe-
notypes exhibited by LVWT and WT viruses. In addition, inhib-
iting StopGo had no or only a slight detrimental effect on the
efficiency of ribosomal frameshifting (Fig. 3C). It has been sug-
gested that the apparent redundancy of StopGo in TMEV may
partly stem from the presence of a potential 3C-Pro cleavage site
within 2B (QG, encoded just downstream from the shift site; also
conserved in EMCV) (22). Cleavage at QG in a StopGo mutant
would yield 2A fused to the N-terminal 9 amino acids of 2B (2A-
2BN) and a separate N-terminally truncated 2B. Consistent with
this, no product of the expected size of 2A-2B (30 kDa) was
observed in the radiolabeling experiment using LVWT virus. In-
stead, a product (or products) migrating slightly more slowly than
WT 2A was observed, consistent with either 2A-2B* or 2A-2BN.
Mass-spectrometric analysis of V5-tagged LVWT confirmed that
V5-tagged products migrating at this size comprise both V5-
tagged 2A-2B* and V5-tagged 2A-2BN. If N-terminally truncated
2B can carry out all necessary 2B functions, then it would appear
that the importance of StopGo is to produce the correct C termi-
nus of 2A and/or the correct N terminus of 2B*. The differing
FIG 5 Analysis of frameshift stimulators. (A) Frameshifting efficiencies measured using dual-luciferase constructs. BHK-21 cells were transfected with frameshift
reporter constructs and 18 h later were either infected with WT virus at an MOI of 10 or mock infected. Lysates were harvested at 7 h p.i. and assayed forRenilla and firefly
luciferase activity. Frameshift efficiencies were determined by comparing luciferase activities to an in-frame control (IFC) construct. Mean values and standard
deviations are shown, each based on nine separate transfections. (B) Western blot verifying infection of infected samples. Aliquots of each of the cell lysates were
separated on a 10 to 20% Tris-Tricine gradient gel and probed with rat monoclonal anti-tubulin (red, IRDye 700-labeled secondary) and mouse monoclonal
anti-VP1 (TMEV capsid protein) (green, IRDye 800-labeled secondary) antibodies. Note that the rat monoclonal primary cross-reacts with both the secondary
antibodies. (C) Schematic representation of the fragments cloned into the pIDluc vector. All constructs contain the U-to-C mutation removing the1 frame
UAA stop codon (red) to allow expression of the downstream luciferase and the C-to-U mutation to introduce a zero-frame UAA stop codon just 3= of the shift
site (see the text). pIDluc IFC contains an extra U in the G_GUU_UUU shift site sequence (blue). (D) Frameshifting efficiencies of dual-luciferase constructs
containing stem-loop mutants. See the description of panel A for details. Mean values and standard deviations are shown, each based on nine separate
transfections.
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susceptibilities of EMCV and TMEV to StopGo inhibition may be
due to 2B* being functional in EMCV but not in TMEV, or per-
haps due to the 2B* that is appended to 2A having a greater inhib-
itory effect on 2A function or L-1ABCD-2A2B* polyprotein pro-
cessing in EMCV due to the larger size of EMCV 2B* (cf. the
polyprotein processing studies in reference 8).
Frameshifting downregulates production of the TMEV non-
structural proteins 2BC-3ABCD by 74 to 82%. During the course
of viral infection, the structural proteins are required in much
greater quantities than the enzymatic proteins, in particular the
viral polymerase. In many RNA viruses, transcriptional or trans-
lational control mechanisms are used to downregulate production
of the latter relative to the former (reviewed in reference 28).
However, in viruses that use a single-polyprotein expression strat-
egy, such mechanisms would appear to be unavailable, and any
regulation of relative protein levels must normally occur post-
translationally, e.g., via polyprotein processing, protein turnover,
the production of inactive conformers, or sequestration of enzy-
matic proteins in inclusion bodies or the nucleus. We suggest that
highly efficient1 PRF in TMEV provides a mechanism to escape
the confines of a single-polyprotein expression strategy, allowing
efficient downregulation of replication protein synthesis while si-
multaneously releasing translational resources for enhanced
structural protein synthesis.
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